Project Grant R43DA054867
Award Date
8/15/24
Completion Date
7/31/25
Dollars Obligated
$644K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Beverly, MA 01915, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a $959,964 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Charles River Analytics, Inc. to design and demonstrate the feasibility of a prototype system called Stimulant Use Recovery via Immersive Virtual Environments (SURVIVE). The goal of SURVIVE is to provide controlled environmental stimulant use disorder (STUD) triggers and cognitive behavioral therapy (CBT) embedded into virtual environments to reduce...
The National Institute on Drug Abuse (NIDA) awarded a $2,302,407 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Albert Einstein College of Medicine to conduct a randomized controlled trial testing the efficacy of an immersive mindfulness virtual reality (VR) intervention for treating chronic pain and opioid use disorder (OUD) in opioid treatment programs. The project aims to enroll 185 participants with chronic pain and OUD in the Bronx, NY to evaluate...
The National Institute on Drug Abuse (NIDA) awarded a $1,919,956 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Illinois to conduct a longitudinal study examining the social and environmental influences on substance use, mental health, and suicidality among non-prescriber/non-executive healthcare workers in the U.S. The objective is to identify modifiable risk and protective factors beyond the individual level, such as the impact of moral...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $290,134 to Palmetto Innovative Education, LLC to develop an interactive 3D digital game called "SimuVersity Medical Center." The game aims to teach health professional students and practicing clinicians modern, empirically-validated strategies for managing chronic pain and opioid use/misuse, particularly in diverse patient populations....
This federal Project Grant award of $605,347 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to validate the reliability and predictive value of a virtual reality-based attentional bias (VR-AB) marker as a biomarker for tobacco use disorder. The award, granted to the University of California, San Diego (UCSD), will support a study to assess the VR-AB marker's ability to predict response to the smoking cessation medication...
The National Institute on Drug Abuse (NIDA) awarded a $2,729,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Rhode Island. The grant, titled "Development and Evaluation of a Mobile Health Intervention for Co-morbid Opioid Use Disorder and Posttraumatic Stress Disorder During Community Re-entry," aims to rigorously develop and evaluate a mobile app that provides 24/7 continuing care and just-in-time adaptive interventions to reduce...
This $136,320 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development and dissemination of an educational intervention focused on advancing data science skills for addiction research. The key products and services to be delivered include: An immersive, tailored "Addiction Data Science Skills" course that provides hands-on training in FAIR data principles, computational analysis...
The National Center for Complementary and Integrative Health (NCCIH) awarded a $254,892 Project Grant under CFDA 93.213 - Research and Training in Complementary and Integrative Health to Ralphvr Inc. The grant supports the development and feasibility testing of a multi-component virtual reality (VR) application called "Virtual Partner" to target a reduction in delirium among patients in the intensive care unit (ICU). The project aims to: 1) gather stakeholder and patient feedback to...
The National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, awarded a $854,122 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Resilient Lifescience, Inc. on September 15, 2024. The purpose of this grant is to support the development of a wearable medical device to detect opioid overdose. The project has an expected completion date of August 31, 2025. The Drug Use and Addiction Research Programs fund a broad range of research...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop new technology-based materials to encourage drug checking, distribution of harm reduction supplies, and linkage to addiction treatment services. The $1,607,146 award to NDRI-USA Inc., a non-profit research organization, will fund the creation of multimedia content in English and Spanish to increase overdose prevention behaviors and...